General Information of This Drug (ID: DME5TUR)

Drug Name
LY03004   DME5TUR
Synonyms Risperidone controlled release
Indication
Disease Entry ICD 11 Status REF
Schizophrenia 6A20 Phase 3 [1]

List of Combinatorial Drugs (CBD) Containing This Drug

53 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
Acamprosate + LY03004 DC9X220 Acamprosate Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Arfolitixorin + LY03004 DCFH555 Arfolitixorin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Bortezomib + LY03004 DCU0C75 Bortezomib Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Doxorubicin + LY03004 DCC2PYH Doxorubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Gefitinib + LY03004 DC0JQ6I Gefitinib Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Imipramine + LY03004 DCYHDD6 Imipramine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
IT-141 + LY03004 DCR1VHE IT-141 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Levamisole + LY03004 DC3MFF2 Levamisole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Baclofen DCU1HRF Baclofen Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Diethylcarbamazine DC21U36 Diethylcarbamazine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Citalopram DCIKM4M Citalopram Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Crotamiton DCY8PP4 Crotamiton Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Trioxsalen DC8Q7XZ Trioxsalen Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Vinblastine DCYV06N Vinblastine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Anamorelin DCC5ANJ Anamorelin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Metyrosine DCYXVVE Metyrosine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Guanfacine DC1N6C6 Guanfacine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Chlorzoxazone DCMBTQC Chlorzoxazone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Docetaxel DCX9T72 Docetaxel Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + JZL195 DCDPLKW JZL195 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Fibrates DC2ZS57 Fibrates Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Mecamylamine DCBEZ5G Mecamylamine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + BIO-300 DC6L2EJ BIO-300 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Trifluoperazine DCC86CB Trifluoperazine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Tamoxifen DCJ1P7L Tamoxifen Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Pargyline DC3Q6LP Pargyline Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Idarubicin DC9PF41 Idarubicin Glioblastoma? (Cell Line: T98G) [2]
LY03004 + Pramipexole DC4L6HU Pramipexole Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Methylene blue DCVD70S Methylene blue Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Topotecan DCXW328 Topotecan Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Cefmenoxime DC3WEM1 Cefmenoxime Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Maprotiline DC6J1X7 Maprotiline Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Leflunomide DCWC44B Leflunomide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Acarbose DCIOVOY Acarbose Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Amiloride DC837XS Amiloride Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Brincidofovir DCDQ5S6 Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Asenapine DCPTHQQ Asenapine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Quinine DC8YYS4 Quinine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Endoxifen DCFIMP6 Endoxifen Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Mycophenolic acid DCC8ZS7 Mycophenolic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Auranofin DC1W5J2 Auranofin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Rufinamide DCYWBCL Rufinamide Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Vorinostat DC20H7P Vorinostat Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Cerivastatin DCRXNG5 Cerivastatin Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Aciclovir DCBQHFP Aciclovir Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
LY03004 + Cytarabine DCNHDYN Cytarabine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
PHA-739358 + LY03004 DCRDY2Y PHA-739358 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
PMID28460551-Compound-2 + LY03004 DCAU62D PMID28460551-Compound-2 Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Raltegravir + LY03004 DCU43WK Raltegravir Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Ribavirin-TP + LY03004 DC6UW4X Ribavirin-TP Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Spironolactone + LY03004 DCWD5OG Spironolactone Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Tiagabine + LY03004 DCZFNJ7 Tiagabine Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
Trihexyphenidyl + LY03004 DCBPMHB Trihexyphenidyl Chronic myelogenous leukemia (Cell Line: KBM-7) [2]
------------------------------------------------------------------------------------
⏷ Show the Full List of 53 DrugCom(s)

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.